Prevalence of heart disease--United States, 2005

    Insights

    State-specific data reveal significant disparities in heart disease prevalence, including myocardial infarction (MI) and angina/coronary heart disease (CHD). Public health programs must target disproportionately affected populations to reduce incidence and eliminate health inequities.

    Area of Science:

    • Cardiovascular epidemiology
    • Public health surveillance
    • Health disparities research

    Background:

    • Heart disease remains the leading cause of death and a major cause of disability in the U.S.
    • Significant healthcare expenditures are associated with heart disease, with coronary heart disease costing billions annually.
    • Previous data lacked state-specific prevalence for heart disease and detailed information on affected populations.

    Purpose of the Study:

    • To estimate the prevalence of myocardial infarction (MI) and angina/coronary heart disease (CHD) across all U.S. states, DC, Puerto Rico, and USVI.
    • To provide the first state-based prevalence estimates for these specific heart conditions.
    • To identify and analyze geographic, racial/ethnic, educational, and sex disparities in heart disease prevalence.

    Main Methods:

    • Analysis of self-reported data from the 2005 Behavioral Risk Factor Surveillance System (BRFSS).
    • Utilized data from all 50 states, the District of Columbia (DC), Puerto Rico, and the U.S. Virgin Islands (USVI).
    • Focused on estimating prevalence of myocardial infarction (MI) and angina/coronary heart disease (CHD).

    Main Results:

    • Substantial geographic disparities in the prevalence of MI and angina/CHD were identified.
    • Significant racial/ethnic, educational, and sex disparities were observed in heart disease prevalence.
    • The study provides the first state-level prevalence data for MI and angina/CHD.

    Conclusions:

    • Public health programs should prioritize interventions for disproportionately affected populations.
    • Addressing health disparities is crucial to lowering heart disease incidence and achieving Healthy People 2010 goals.
    • Targeted public health strategies are necessary to combat inequities in heart disease prevalence.

    Related Concept Videos

    Coronary Artery Disease IV: Preventive Measures01:26

    Coronary Artery Disease IV: Preventive Measures

    Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
    Ischemic Heart Disease: Overview01:17

    Ischemic Heart Disease: Overview

    Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
    Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
    Coronary Artery Disease I: Introduction01:30

    Coronary Artery Disease I: Introduction

    Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Prevalence and Incidence01:08

    Prevalence and Incidence

    In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
    Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
    Coronary Artery Disease III: Clinical Manifestations01:30

    Coronary Artery Disease III: Clinical Manifestations

    Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...